Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After A Sharp One Month Share Price Pullback [Yahoo! Finance]
Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.tevapharm.com
Company Research
Source: Yahoo! Finance
Recent performance snapshot and what it might mean for investors Teva Pharmaceutical Industries (TEVA) has seen mixed share performance recently, with a 3.5% decline over the past day and a 15.1% decline over the past month, following strong 1 year and multi year total returns. At a last close of US$28.74 and a market cap of about US$33.5b, Teva Pharmaceutical Industries sits in the large cap bracket. This can matter for liquidity and the type of investors following the stock. See our latest analysis for Teva Pharmaceutical Industries. That recent 15.1% 1 month share price decline comes after a strong run, with total shareholder return of 87% over 1 year and more than tripling over 3 years, which suggests momentum has cooled as investors reassess growth prospects and risks. If Teva's recent pullback has you thinking about where else to look in healthcare, this can be a good moment to broaden your search with 33 healthcare AI stocks With Teva trading at US$28.74 and appear
Show less
Read more
Impact Snapshot
Event Time:
TEVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TEVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TEVA alerts
High impacting Teva Pharmaceutical Industries Limited American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TEVA
News
- Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) [Yahoo! Finance]Yahoo! Finance
- Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)GlobeNewswire
- Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026 [Yahoo! Finance]Yahoo! Finance
- Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026GlobeNewswire
- Teva Releases Q1 2026 Aide MemoireGlobeNewswire
TEVA
Earnings
- 1/28/26 - Beat
TEVA
Sec Filings
- 3/19/26 - Form 4
- 3/17/26 - Form 144
- 3/9/26 - Form 4
- TEVA's page on the SEC website